Liver disease treatment in India for Kazakhstani patients has become one of the most sought-after medical travel options in Central Asia and for a very clear reason. Kazakhstan has a chronic hepatitis B epidemic that no other Central Asian country faces to the same degree. Between 3 and 4 percent of Kazakhstan’s population carries a chronic hepatitis B infection. In real terms, approximately 600,000 to 800,000 Kazakhstanis are living with chronic HBV, and a significant proportion will progress to liver cirrhosis, liver failure, or hepatocellular carcinoma (liver cancer) without adequate treatment.
The treatment pathway in Kazakhstan, antiviral therapy, regular monitoring, FibroScan, liver biopsy, and ultimately transplant evaluation is available but often at prices that are prohibitive in private hospitals and with waiting times in the public system that can span years. That is why liver disease treatment in India has emerged as the most cost-effective and clinically advanced alternative in the region. This guide explains exactly what India offers, what it costs, and which hospitals deliver the best results for CIS patients.
Kazakhstan’s Liver Disease Burden: Why This Matters for Your Treatment Decision
Kazakhstan has a well-documented clinical course for hepatitis B. Chronic HBV infection causes continuous liver inflammation. This inflammation damages the liver over years and causes scarring (fibrosis). If left untreated or not managed properly, fibrosis progresses to cirrhosis, in which the architecture of the liver is permanently altered, and its functions gradually deteriorate.
Serious complications at the cirrhosis stage include portal hypertension, esophageal varices, ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, and hepatorenal syndrome. Liver cancer, called hepatocellular carcinoma (HCC), occurs in 2–5% of people with cirrhosis each year. Eventually, a liver transplant becomes a cure for many patients.
The progression is well known to India’s hepatologists, since they deal with it on a daily basis. In total, the Institute of Liver and Biliary Sciences (ILBS) in Delhi and the Medanta Liver Institute and hepatobiliary program of BLK-Max treat thousands of liver diseases related to hepatitis B every year, including those from Kazakhstan, Uzbekistan, and Russia. Liver disease treatment in India is available at an affordable price for Kazakhstani families and also has internationally accredited expertise!
Liver Diseases Treated in India for CIS Patients
Chronic Hepatitis B—Antiviral Therapy and Monitoring
Hepatitis B treatment in India is based on oral antiviral drugs: tenofovir (TDF), entecavir, or tenofovir alafenamide (TAF). These inhibit the further production of virus particles and thus stop further damage to the liver. The price of a year’s supply of 100% tenofovir (generic) in India is $1.20 to $20.00. The same drug in the private pharmacies in Kazakhstan costs $100 – $150 per year. Hepatitis B treatment in India is made more affordable by its government-approved generic manufacturing process.
Treatment also involves regular monitoring (viral load test (HBV DNA), liver function tests (LFT), α-fetoprotein (AFP) testing (cancer monitoring), and fibroscan (every 6-12 months)). These can all be organized during a planned visit to India, and the outcomes can be followed up on in Kazakhstan.
Hepatitis C—Curative Treatment in India
The treatment for Hepatitis C is 12-week direct-acting antivirals (DAAs): sofosbuvir-ledipasvir, sofosbuvir-velpatasvir, or glecaprevir-pibrentasvir. In most of the genotypes, the cure rate is more than 95 percent. The cost of the entire 12-week generic DAA treatment is $500-$1,500 in India, which is 20 times cheaper than branded DAA treatment in the USA, $30,000-$80,000 in Kazakhstan’s private healthcare system, and $1,500-$4,000 in Pakistan. Treatment of Hepatitis C can be organized by MediKaya Healthcare, and all the tests can be conducted in a single organized visit to India—viral genotyping, treatment, and end-of-treatment viral load testing.
Liver Cirrhosis—Management and Complication Control
There are a few and only the most reliable interventions to manage the complications of liver cirrhosis in India. The interventions include use of diuretics for managing ascites, TIPS for managing refractory ascites and hepatic encephalopathy, and esophageal variceal banding. The goal of treating liver cirrhosis and its complications is to improve the quality of life. It is worth noting that a MELD score of 15 or more indicates that a patient should consider a liver transplant.
Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH
One of the most widespread liver conditions internationally, NAFLD is on the rise in Kazakhstan along with obesity. MediKava Healthcare has noted an increase in patients from Kazakhstan requiring treatment for NAFLD in India. Hepatologists in India have reported utilizing lifestyle modifications and pharmacotherapy along with bariatric surgery to treat patients with NAFLD. MediKava provides combined care for obesity-related liver disease.
Hepatocellular Carcinoma (Liver Cancer)—Treatment in India
Treatment of HCC arising from hepatitis B cirrhosis includes surgery (hepatectomy), ablation (radiofrequency or microwave), transarterial chemoembolization (TACE), targeted therapy (sorafenib or lenvatinib), and liver transplant (if within Milan criteria). The teams in interventional hepatology in India conduct hundreds of cases of TACE and device ablations every year at 60-70% lower prices than the European centers.
Liver Disease Treatment Cost in India vs Kazakhstan vs Turkey — 2026
| Procedure | 🇮🇳 India | 🇰🇿 Kazakhstan | 🇹🇷 Turkey | 🇩🇪 Germany |
|---|---|---|---|---|
| Hepatitis C — Full 12-week DAA course | $500–$1,500 | $3,000–$8,000 | $2,000–$5,000 | $8,000–$2,000 |
| Hepatitis B Antiviral (1 year, generic) | $200–$400 | $800–$1,500 | $600–$1,200 | $2,000–$4,000 |
| Fibroscan (Liver Stiffness Test) | $60–$120 | $200–$400 | $150–$300 | $300–$600 |
| Liver Biopsy | $300–$600 | $800–$1,500 | $600–$1,200 | $1,500–$3,000 |
| TIPS Procedure | $2,000–$4,000 | $6,000–$12,000 | $5,000–$9,000 | $12,000–$20,000 |
| TACE for Liver Cancer | $2,500–$4,500 | $7,000–$12,000 | $5,000–$9,000 | $12,000–$22,000 |
| Liver Transplant (Living Donor) | $22,000–$27,000 | Limited / $50,000 | $35,000–$50,000 | $100,000–$150,000 |
Living Donor Liver Transplant—Can a Family Member from Kazakhstan Donate?
Yes, and this is the most important question for families looking for liver disease treatment in India for Kazakhstan patients who need a liver transplant. In a living donor liver transplant (LDLT), approximately 60 percent of the donor’s liver is used for the transplant recipient. The other part of the liver grows back to its normal size in 6-8 weeks. The hospital stay is 5-7 days, and complete recovery to normal activity is 4-6 weeks.
The following persons can be living donors in Kazakhstan: parents, siblings, adult children (aged 18 years and over), and spouses. The first requirement is blood group compatibility. Best if between 18 and 55 years of age. The ideal BMI is less than 30. The donor should not have any major liver disease and be healthy overall. In India, an in-depth evaluation is done within seven to 14 days prior to the transplant, which includes CT liver volumetry, an echocardiogram, a psychiatric evaluation, and a full blood panel.
Top Hospitals for Liver Disease Treatment in India for Kazakhstani Patients
- Institute of Liver and Biliary Sciences (ILBS), Delhi: India’s only government hospital dedicated exclusively to liver disease. Handles the highest volume of hepatitis B-related cirrhosis in India. Significantly lower cost than private hospitals. MediKaya coordinates international patient access to ILBS.
- Medanta Liver Institute, Gurugram: Performs 200+ liver transplants annually. Led by internationally trained hepatobiliary surgeons. A comprehensive program covering all stages of liver disease from hepatitis to transplant. JCI accredited.
- BLK-Max Super Specialty Hospital, Delhi: MediKaya’s primary partner. A full liver disease program including advanced hepatology, TACE, ablation, and liver transplant. Russian-speaking CIS patient coordinator on staff.
- Fortis Memorial Research Institute, Gurugram: Strong liver program, particularly for advanced cirrhosis and hepatocellular carcinoma. JCI accredited. International patient department with experienced coordination team.
Frequently Asked Questions
Q: How much does hepatitis B treatment cost in India for Kazakhstani patients?
A: The annual cost of branded Hepatitis B treatment (Teno-B/Viread) in India is USD 200 to 400. In Kazakhstan the cost of the drug is 60-80% higher. A complete liver disease management program in India is approximately USD 400 to 800, which includes a specialist consultation, liver function tests, Fibroscan, AFP, and viral load tests. MediKaya Healthcare has tied up with leading hospitals to provide integrated management of liver disease for patients from Kazakhstan.
Q: Can hepatitis C be cured in India?
A: India is among the few countries which has access to cheaper prices of direct acting anti viral (DAA) drugs for hepatitis C (HCV) infection. Curing HCV infection is much easier and faster as compared to treating HBV infection. The cost of curative therapy of HCV infection in India is in the range of USD 3,000 to 8,000 as compared to USD 500 to 1500 in private health care facilities of Kazakhstan. India offers complete management of HCV infection including genotype testing, HCV treatment and confirmation of HCV cure by post treatment viral load tests.
Q: What documents should I send to get a free liver disease evaluation?
A: Send your liver function tests (ALT, AST, Bilirubin, Albumin, INR/PT), Hepatitis B surface Antigen, Hepatitis B viral load (if available), Alpha-Fetoprotein, Abdominal US/CT (if available), and previous FibroScan reports to us via WhatsApp. Our experts will review your case and get back to you within 48 hours.
Q: What’s the difference between liver failure and cirrhosis?
A: Cirrhosis is the end stage of chronic, progressive liver disease. In this process, healthy liver tissue is permanently replaced by scar tissue. At this stage, the liver is small in size and cells are not able to perform its normal function at an optimal level. Liver failure is the complete inability of the liver to perform its normal function.
Q: What is a MELD score, and why does it matter for liver transplants?
A: MELD is a score that indicates the severity of liver failure. This score is determined by three tests, i.e. Bilirubin, INR and Creatinine. A score of 15 or more warrants consideration for liver transplant evaluation. Score of 20 or more indicates transplant should be considered as an urgency case. India’s liver transplant teams make determination for liver transplant based on MELD score. We will calculate your estimated MELD score, free of charge, upon receiving your LFT results from MediKaya Healthcare.
Лечение заболеваний печени в Индии для пациентов из Казахстана — 2026
Казахстан занимает первое место в Центральной Азии по уровню хронического гепатита B: 3–4% населения — носители вируса. Именно он является основной причиной цирроза печени, печёночной недостаточности и рака печени в стране.
Стоимость лечения в Индии:
- Полный курс лечения гепатита C (12 недель): $500 –$1,500 против $3,000–$8,000 в Казахстане
- Антивирусная терапия гепатита B (генерики, 1 год): $200–$400 против $800–$1,500
- Фибросканирование: $60–$120
- Пересадка печени от живого донора: $25,000–$35,000 против $100,000–$150,000 в Германии
Родственник пациента (родитель, брат/сестра, ребёнок старше 18 лет, супруг) может стать донором части печени. MediKaya Healthcare обеспечивает бесплатную оценку вашего случая за 48 часов и полное русскоязычное сопровождение.